Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-05-29
1992-02-25
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514331, 546237, 546240, 546192, 546230, 546233, 546234, 546235, A61K 31445, C07D21120
Patent
active
050913930
ABSTRACT:
The invention relates to a group of tertiary 2,5-dialkyl-3-phenylpiperidine derivatives, having opiate-antagonistic activity represented by general formula 4, ##STR1## wherein A.sub.1 is hydrogen, an optionally esterified hydroxyl group or mercapto group, a group NHA.sub.8 or --CONHA.sub.8, wherein A.sub.8 is hydrogen, alkyl having 1-6 C-atoms or alkylcarbonyl having 2-7 C-atoms;
REFERENCES:
patent: 4081450 (1978-03-01), Zimmerman
patent: 4284635 (1981-08-01), Zimmerman
patent: 4593037 (1986-06-01), Sarges
Chemical Abstracts, 74:22700h (1971), "Butyrophenone Derivatives."
M. Iorio et al., J. Med. Chem., 21(8), "Nalorphine-like properties of some 2,3-dimethyl-3-arylpiperdines (1978)".
Den Hartog Jacobus A.
Tulp Martinus T.
Van Wijngaarden Ineke
Duphar International Research B.V.
Raymond Richard L.
Russell Mark W.
LandOfFree
Tertiary 2,5-dialkyl-3-phenylpiperidine derivatives having opiat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tertiary 2,5-dialkyl-3-phenylpiperidine derivatives having opiat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tertiary 2,5-dialkyl-3-phenylpiperidine derivatives having opiat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1893152